Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

    Investing

    • Inheritance TaxInheritance Tax
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Client Area and Conectus Portal
  • Contact Us

Market News - Page 745

21 May 2018

AstraZeneca PLC – Regulatory submission in Japan for Forxiga in type-1 diabetes

AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for the use of Forxiga (dapagliflozin), a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor, as an oral adjunct treatment to insulin in adults with type-1 diabetes (T1D)….

21 May 2018

AstraZeneca PLC US FDA approves Lokelma for adult hyperkalaemia

The US Food and Drug Administration (FDA) has approved Lokelma (sodium zirconium cyclosilicate), formerly ZS-9, for the treatment of adults with hyperkalaemia,1 a serious condition characterised by elevated potassium levels in the blood associated with cardiovascular, renal and metabolic diseases.2…

21 May 2018

Melrose Industries PLC – Delisting of GKN & Continuation Of Offer

Further to the announcements released by Melrose and GKN plc (“GKN”) on 19 April 2018, Melrose announces that the listing of GKN's ordinary shares of 10 pence each (“GKN Shares”) on the Official List of the UK Listing Authority was cancelled with effect from 8:00 a.m. (London time) today, 21 May 2018. The GKN Shares ceased to be admitted to trading on the London Stock Exchange's Main Market for listed securities with effect from the same time….

21 May 2018

NewRiver REIT Plc – Response to Press Speculation

NewRiver notes press comment regarding the potential acquisition of Hawthorn Leisure Holdings Limited (“Hawthorn”). NewRiver confirms that it has entered a period of exclusivity with Hawthorn and its major shareholder regarding a potential acquisition of the business. A transaction, if completed, would be funded from NewRiver's existing resources. There can be no certainty that a transaction will be concluded and a further announcement, as appropriate, will be made as soon as practicable….

18 May 2018

Watkin Jones PLC – Update on Build to Rent Developments

Watkin Jones plc (AIM:WJG), a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation and build to rent sectors, confirms that the Group has entered into a development arrangement with M&G Real Estate ('M&G') and Lochailort to deliver a 315 apartment build to rent scheme in Reading. …

18 May 2018

J Sainsbury PLC – Merger update

On 30 April 2018, J Sainsbury PLC (Sainsbury's) and ASDA Group Limited (ASDA
and, together with Sainsbury's, the Parties) announced that they have entered
into an agreement to combine their operations (the Proposed Merger).
…

18 May 2018

AstraZeneca PLC – First Quarter 2018 Results

Encouraging launches and the performance of newer medicines underpin reiterated guidance…

18 May 2018

Lloyds Banking Group – announces sale of its Irish Residential Mortgage Portfolio.

Lloyds Banking Group plc (the 'Group') announces today that it has agreed the sale of its Irish residential mortgage portfolio to Barclays Bank plc, for a cash consideration of around £4 billion at current exchange rates….

Posts navigation

  • «
  • 1
  • …
  • 743
  • 744
  • 745
  • 746
  • 747
  • …
  • 853
  • »

Home > Market News > Page 745

James Sharp white Logo
Sign In
X Twitter Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

X Twitter Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Client Area and Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© Copyright 2010-2025. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG